U.S. flag

An official website of the United States government

Display Settings:

Format
Sort by

Send to:

Choose Destination

Links from Nucleotide

Items: 5

1.
Targeting heterotopic ossification by inhibiting activin receptor-like kinase 2 function
Fuli Shi, Jiayu Gao, Junrong Zou, Ying Ying, Hui Lin
Mol Med Rep. 2019 Oct; 20(4): 2979–2989. Published online 2019 Aug 6. doi: 10.3892/mmr.2019.10556
PMCID:
PMC6755183
ArticlePDF–575K
2.
Cross-talk among AFAP1-AS1, ACVR1 and microRNA-384 regulates the stemness of pancreatic cancer cells and tumorigenicity in nude mice
Xu-Bo Wu, Xia Feng, Qi-Meng Chang, Cheng-Wu Zhang, Zhi-Fei Wang, Jie Liu, Zhi-Qiu Hu, Jia-Zhe Liu, Wei-Ding Wu, Zi-Ping Zhang, Xi-Qiang Liu
J Exp Clin Cancer Res. 2019; 38: 107. Published online 2019 Feb 28. doi: 10.1186/s13046-019-1051-0
PMCID:
PMC6396461
ArticlePDF–2.2M
3.
MicroRNA-384 inhibits the progression of breast cancer by targeting ACVR1
Yongxia Wang, Zheying Zhang, Jianqiang Wang
Oncol Rep. 2018 Jun; 39(6): 2563–2574. Published online 2018 Apr 20. doi: 10.3892/or.2018.6385
PMCID:
PMC5983929
ArticlePDF–2.7M
4.
Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor.
K Tsuchida, L S Mathews, W W Vale
Proc Natl Acad Sci U S A. 1993 Dec 1; 90(23): 11242–11246. doi: 10.1073/pnas.90.23.11242
PMCID:
PMC47958
SummaryPage BrowsePDF–1.2M
5.
ACVR1, a Therapeutic Target of Fibrodysplasia Ossificans Progressiva, Is Negatively Regulated by miR-148a
Hao Song, Qi Wang, Junge Wen, Shunai Liu, Xuesong Gao, Jun Cheng, Deli Zhang
Int J Mol Sci. 2012; 13(2): 2063–2077. Published online 2012 Feb 15. doi: 10.3390/ijms13022063
PMCID:
PMC3292007
ArticlePDF–364K

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center